300811-62-5

Basic information

• Product Name: 2-(benzyloxy)-6-bromoquinoline
• Synonyms: 2-(benzyloxy)-6-bromoquinoline
• CAS NO: 300811-62-5
• Molecular Weight: 314.181
• Mol File: 300811-62-5.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 2-(benzyloxy)-6-bromoquinoline(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(benzyloxy)-6-bromoquinoline(300811-62-5)
• EPA Substance Registry System: 2-(benzyloxy)-6-bromoquinoline(300811-62-5)

Safety Data

• Hazardous Substances Data: 300811-62-5(Hazardous Substances Data)

Upstream product

• 1810-66-8 6-bromoquinoline-2-ol 
• 100-39-0 benzyl bromide 
• 1810-71-5 6-bromo-2-chloroquinoline 
• 100-51-6 benzyl alcohol 
• 1810-66-8 6-bromo-2-quinolone 

Downstream Products

• 300811-64-7 C₄₂H₃₁BrN₂O₂ 
• 300811-70-5 C₄₂H₃₂N₂O₂ 
• 300811-63-6 2-benzyloxy-6-quinolinecarboxaldehyde 

Relevant articles and documents

INHIBITORS OF FATTY ACID AMIDE HYDROLASE

The present invention provides compounds, and pharmaceutically acceptable compositions thereof, encompassed by any of formulae (I), (II), (III), (IV), (V), or (VI), or subgenera thereof. The present invention also provides methods for treating an FAAH mediated disease, disorder or condition by administering a therapeutically effective amount of a compound or composition comprising a compound of any of formulae (I), (II), (III), (IV), (V), or (VI), or subgenera thereof, to a patient in need thereof. Additionally, the present invention provides methods for inhibiting FAAH by administering a therapeutically effective amount of a compound or composition comprising a compound of any of formulae (I), (II), (III), (IV), (V), or (VI), or subgenera thereof, to a patient in need thereof.

Chiral discrimination in hydrogen-bonded [7]helicenes

(matrix presented) A series of racemic [7]helicenes have been prepared and characterized both in solution and in the solid state. Despite the helicenes having the ability to self-assemble in a variety of stereochemical and topological relationships, they